We have liftoff! 🚀 Dexcom has always believed in pushing the boundaries of what’s possible with our biosensing technology, and today, we’ve achieved another remarkable first: Our G6 CGM System is being used in scientific research during the Polaris Dawn space mission. Astronauts will be wearing #DexcomCGM to test the effects of space travel on human health, including glucose health. ✨ At Dexcom, our mission is to empower all people - including astronauts in space – to take control of health. #Dexcom #diabetes Learn more. https://lnkd.in/gAFCbdQF
Dexcom Inc.
Herstellung medizinischer Geräte
San Diego, California 156.651 Follower:innen
Empowering people to take control of health
Info
Die Firma Dexcom Inc. wurde 1999 gegründet und bietet eine Technologie zur kontinuierlichen Glukoseüberwachung an, die Patienten und ihre Ärzte dabei unterstützt, den Diabetes besser in den Griff zu bekommen. Seit unserer Gründung konzentrieren wir uns darauf, durch Bereitstellung von Lösungen für Diabetiker bessere Behandlungserfolge für Patienten, Pflegekräfte und Ärzte zu ermöglichen – und gleichzeitig unsere Patienten und Partner in die Lage zu versetzen, die Kontrolle über den Diabetes zu übernehmen.
- Website
-
https://careers.dexcom.com/careers/index
Externer Link zu Dexcom Inc.
- Branche
- Herstellung medizinischer Geräte
- Größe
- 10.001+ Beschäftigte
- Hauptsitz
- San Diego, California
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 1999
- Spezialgebiete
- Continuous Glucose Monitoring, Medical Devices, Diabetes, Decision Support, Data, Mobile Software und Sensors
Orte
Beschäftigte von Dexcom Inc.
-
Rob Booker
Consultant - Medical Device Engineering and Quality
-
Tiernan Hussey, MBA, PMP, PMI-ACP, CLP, CSM, LSSGB, Prosci
Accomplished, highly experienced and seasoned business professional with decades of experience in IT project and program management, corporate…
-
Sandy Struss, MBA
-
Vijay Adusumilli
Senior Salesforce Solutions Architect
Updates
-
EASD 2024 - let's think better together. Join our Symposium to hear different expert perspectives and get practical knowledge to help your practice. https://qrco.de/bf8IIo
-
+1
-
We are headed to Madrid this week for the 60th annual European Association for the Study of Diabetes e.V. (EASD) Conference where we will highlight the transformational impact of Dexcom CGM including: ✅Extensive clinical evidence supporting improved outcomes for patients only when using Dexcom-powered AID systems ✅Expanding body of data reinforcing the positive impact of our #CGMtechnology for people living with Type 2 diabetes To spotlight the real-world benefits of #DexcomCGM on clinical practice, we are bringing a panel of experts from across Europe together for Dexcom’s EASD Symposium on Monday, September 9 from 1300 -1430 CEST. Learn more about our symposium and presence at #EASD2024 here https://qrco.de/bf8IIo. #EASD2024 #DexcomCGM #DiabetesManagement
Dexcom at EASD 2024-Dexcom-234
s.tiled.co
-
Stelo by Dexcom, the first over-the-counter glucose biosensor in the U.S., is now available for purchase at Stelo.com. With no prescription required, this category-defining product will make glucose tracking easier than ever and empower the 125 million Americans with pre-diabetes or Type 2 diabetes not using insulin to own their health with personalized insights. Built on Dexcom’s most accurate glucose biosensing technology, here are some of Stelo’s unique and innovative features: • No fingersticks, no prescriptions • Personalized glucose insights • Meal, activity, and sleep tracking • Spike and pattern detection • Proven results with Dexcom glucose sensors† • Up to 15-day wear time‡ and waterproof§ This milestone represents a new era for the industry, and we’re proud to be leading the way. For full information on risks and benefits, visit stelo.com #Stelo #Dexcom #diabetes #glucosebiosensor *Smart device sold separately. For Stelo app compatibility information, visit stelo.com/compatibility. †Results obtained from previous Dexcom device(s) in people with diabetes who may be on insulin. ‡A study was conducted to assess the sensor life where 77.9% of sensors lasted the full 15 days. In other words, when using the product per the package labeling, approximately 20% of sensors may not last for the full 15 days, 10% of these sensors may last less than 12 days. §The Stelo biosensor is waterproof and may be submerged under eight feet of water for up to 24 hours without failure when properly installed. If you are in or near water, your smartphone may need to be closer than 20 feet to get readings. If you are in water, you may not get readings until you get out.||Cardiovascular risk refers to 10-year ASCVD risk. Visit https://lnkd.in/eVcjT4SQ to access the American College of Cardiology ASCVD Risk Estimator Plus.
-
This summer, our U.S. interns got hands-on experience across various departments, contributing to projects that make a real difference in the lives of people living with diabetes. We're so proud of what they accomplished. Read our latest article to learn more.
Shaping the Future of Innovation: Dexcom's U.S. Internship Program
Dexcom Inc. auf LinkedIn
-
Meet Dexcom’s newest Warrior: Lance Bass, American actor, singer, and producer best known as a member of *NSYNC. Lance was diagnosed with Type 2 diabetes a few years ago. Using his #DexcomG7, he was able to see how unpredictable his glucose levels were and raised these concerns with his doctor. Additional tests revealed that Lance was misdiagnosed with Type 2 diabetes, and he was properly diagnosed with Type 1.5 or latent autoimmune diabetes in adults (LADA), which is when the pancreas slowly stops making insulin in adulthood. By becoming a Dexcom Warrior, Lance is hoping to inspire others to advocate for themselves and take control of their health. Lance recently opened up about his misdiagnosis for the first time with Yahoo Life. Read more about how he manages his diabetes with Dexcom here: https://lnkd.in/gwxkbiER
Lance Bass didn’t know that type 1.5 diabetes existed, until he was diagnosed with it. Here are 6 things he’s learned since.
yahoo.com
-
We're proud to be recognized as a #BestPlacetoWork24 for Disability Inclusion by @DisabilityIN. Dexcom is committed to fostering an inclusive and supportive work environment for all employees. Read more about how our employees are making a difference, and how you can join us and help foster a culture where everyone can thrive.
Dexcom Recognized as a Best Place to Work for Disability Inclusion
Dexcom Inc. auf LinkedIn
-
We’re gearing up for the 2024 Children With Diabetes’ Friends for Life conference. This annual event is always a highlight for our Dexcom team. It gives us the opportunity to connect with and provide education and support for children with Type 1 diabetes and their parents. For this year’s ‘Roaming with Dinosaurs, Advancing with Science’ theme, we’ll be hosting an educational scavenger hunt that follows the evolution of diabetes technology; a dinosaur themed movie night; product theaters to demonstrate #DexcomCGM – and so much more. If you’re in Orlando, stop by the Dexcom booth for an adventure 25 years in the making. #DexcomFFL
-
Today, on International Women in Engineering Day, we’re honored to celebrate women engineers across the globe. From Operations to R&D and IT, Dexcom’s engineers play a crucial role in our mission of empowering people to take control of health. We’re proud to recognize all women engineers who are driving innovation, pushing boundaries, and reshaping the future of technology. #INWED24 #womenintech #gamechangingtechnology #lifechangingwork #Dexcom
-
This week at the 84th Scientific Sessions of the American Diabetes Association conference, we will present new data: • Reaffirming the benefits of #DexcomCGM for people with Type 1, Type 2, and prediabetes. • Demonstrating improved outcomes for people with Type 2 diabetes, including those using #DexcomCGM in combination with GLP-1s. Dexcom also continues our leadership in product innovation and connectivity with the Dexcom G7 and Omnipod 5 Automated Insulin Delivery System integration, and multiple Dexcom G7 app updates, including Direct to Apple Watch. Learn more about our presence at #ADA2024 [link here: https://lnkd.in/g_JXz4xu] And for those attending ADA this year, visit the 𝐃𝐞𝐱𝐜𝐨𝐦 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐄𝐝𝐮𝐜𝐚𝐭𝐢𝐨𝐧 𝐑𝐞𝐬𝐨𝐮𝐫𝐜𝐞𝐬 𝐌𝐢𝐜𝐫𝐨𝐬𝐢𝐭𝐞 for program information [link here: https://lnkd.in/ge5MPxDF]
Verbundene Seiten
Ähnliche Seiten
Aktien
DXCM
NASDAQ
Verzögerung von 20 Minuten
68,82 $
0,35 (0,511 %)
- Aktiv
- 68,47
- Niedrig
- 67,344
- Hoch
- 69,3
Daten von Refinitiv
Mehr Informationen aufFinanzierung
Letzte Runde
Fremdkapital nach Börsengang1.000.000.000,00 $